In Every Issue
Biktarvy and antacids. Descovy FDA hearing. Updated guidelines for transgender individuals. Biktarvy and kids. PrEP4Love. Michael Johnson freed.
Public-private partnerships for a vaccine sustain a global response to help end HIV
IAS 2019 Conference Update
And other conference highlights including new long-acting drug GS-6207; PrEP on demand; HIV treatment = prevention.
Based on new data, the World Health Organization (WHO) recommended dolutegravir as a preferred HIV drug for all populations living with HIV, including pregnant women and those wanting to conceive.
Current and new strategies to achieve HBV and HIV cure, and synergies between the two fields.